Digestive & Intestinal Remedies (Pharmacies) - Australia

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$83.93m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.10%, resulting in a market volume of US$93.10m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$3.14 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Australia is experiencing steady growth due to several factors.

Customer preferences: Customers in Australia are increasingly seeking natural and organic remedies for digestive and intestinal issues. They are becoming more conscious of their health and are willing to invest in products that are perceived to be safer and more effective. This preference for natural remedies is driving the demand for herbal and homeopathic products in the Digestive & Intestinal Remedies market.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Australia is the rising popularity of probiotics. Probiotics are live microorganisms that provide health benefits when consumed. They are known to improve digestion and promote a healthy gut. As awareness about the importance of gut health increases, more consumers are turning to probiotic supplements and foods. This trend is driving the growth of the market. Another trend in the market is the increasing availability of digestive and intestinal remedies in different formats. Previously, these remedies were primarily available in tablet or capsule form. However, there has been a shift towards more convenient formats such as chewable tablets, gummies, and powders. This allows consumers to choose products that suit their preferences and lifestyles.

Local special circumstances: Australia has a high prevalence of digestive and intestinal issues among its population. Factors such as stress, poor diet, and sedentary lifestyles contribute to these issues. As a result, there is a strong demand for remedies that can alleviate symptoms such as indigestion, bloating, and constipation. The local market is responding to this demand by offering a wide range of products that cater to different needs and preferences.

Underlying macroeconomic factors: The Australian healthcare system is well-developed and provides easy access to healthcare services and products. This accessibility contributes to the growth of the Digestive & Intestinal Remedies market as consumers can easily seek advice from healthcare professionals and purchase the necessary remedies. Additionally, the aging population in Australia is driving the demand for digestive and intestinal remedies. As people age, they are more prone to digestive issues and are more likely to seek remedies to alleviate their symptoms. This demographic trend is expected to continue in the coming years, further fueling the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Australia is growing steadily due to customer preferences for natural remedies, the rising popularity of probiotics, the availability of remedies in different formats, the high prevalence of digestive and intestinal issues, the accessibility of healthcare services and products, and the aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.